| CA136551A (en) | 1911-08-03 | 1911-10-31 | Hedwig Heeron | Rolling mill |
| US4690915A (en) | 1985-08-08 | 1987-09-01 | The United States Of America As Represented By The Department Of Health And Human Services | Adoptive immunotherapy as a treatment modality in humans |
| IE20030749A1 (en) | 1991-05-03 | 2003-11-12 | Indiana University Foundation | Human notch and delta binding domains in torporythmic proteins, and methods based thereon |
| US5420032A (en) | 1991-12-23 | 1995-05-30 | Universitge Laval | Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence |
| US5792632A (en) | 1992-05-05 | 1998-08-11 | Institut Pasteur | Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
| US5780300A (en) | 1995-09-29 | 1998-07-14 | Yale University | Manipulation of non-terminally differentiated cells using the notch pathway |
| US6451995B1 (en) | 1996-03-20 | 2002-09-17 | Sloan-Kettering Institute For Cancer Research | Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods |
| RO120850B1 (en)* | 1996-11-07 | 2006-08-30 | Imperial College Of Science Technology & Medic | Notch |
| EP1109921A4 (en) | 1998-09-04 | 2002-08-28 | Sloan Kettering Inst Cancer | FOR PROSTATE-SPECIFIC MEMBRANE-ANTI-SPECIFIC FUSION RECEPTORS AND THEIR USE |
| AU2001265346A1 (en) | 2000-06-02 | 2001-12-17 | Memorial Sloan-Kettering Cancer Center | Artificial antigen presenting cells and methods of use thereof |
| US6984522B2 (en) | 2000-08-03 | 2006-01-10 | Regents Of The University Of Michigan | Isolation and use of solid tumor stem cells |
| US6689744B2 (en) | 2000-09-22 | 2004-02-10 | Genentech, Inc. | Notch receptor agonists and uses |
| US20030119771A1 (en) | 2001-08-22 | 2003-06-26 | Rompaey Luc Van | Modulators of bone homeostasis identified in a high-throughput screen |
| JP2003093048A (en)* | 2001-09-26 | 2003-04-02 | Asahi Kasei Corp | Culture medium for producing new cellular preparation |
| US20030170238A1 (en) | 2002-03-07 | 2003-09-11 | Gruenberg Micheal L. | Re-activated T-cells for adoptive immunotherapy |
| ES2292994T3 (en) | 2002-03-15 | 2008-03-16 | Cellectis | SIMPLE HYBRID AND CHAIN MEGANUCLEASES AND ITS USE. |
| WO2003087159A2 (en)* | 2002-04-05 | 2003-10-23 | Lorantis Limited | Modulators of the notch signalling pathway and uses thereof in medical treatment |
| US7446190B2 (en) | 2002-05-28 | 2008-11-04 | Sloan-Kettering Institute For Cancer Research | Nucleic acids encoding chimeric T cell receptors |
| WO2004032969A1 (en)* | 2002-10-09 | 2004-04-22 | Lorantis Limited | Modulation of immune function |
| WO2004064863A1 (en)* | 2003-01-23 | 2004-08-05 | Lorantis Limited | Treatment of autoimmune diseases using an activator for the notch signaling pathway |
| CA2514517A1 (en) | 2003-01-28 | 2004-08-12 | Cellectis | Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| WO2006056061A1 (en)* | 2004-11-24 | 2006-06-01 | Val-Chum, S.E.C. | Methods to identify, prepare, and use naive t cell recent thymic emigrants |
| WO2007027226A2 (en)* | 2005-04-28 | 2007-03-08 | Board Of Regents, The University Of Texas System | Systems and methods for the production of differentiated cells |
| EP1945762B1 (en) | 2005-10-18 | 2013-05-01 | Precision Biosciences | Rationally-designed meganucleases with altered sequence specificity and dna-binding affinity |
| JP5478254B2 (en) | 2006-10-19 | 2014-04-23 | ジェネンテック， インコーポレイテッド | Anti-Notch3 agonist antibodies and their use in the treatment of Notch3-related diseases |
| CL2007002989A1 (en) | 2006-10-19 | 2008-05-16 | Genentech Inc | ANTI-NOTCH3 ANTIBODIES; NUCLEIC ACID CODING THEM; VECTOR AND CELL THAT UNDERSTANDS IT; METHOD OF PRODUCTION; AND ITS USE FOR THE DIAGNOSIS OF DISEASES RELATED TO NOTCH3. |
| EP2115128A2 (en)* | 2007-01-30 | 2009-11-11 | Deutsches Rheuma-Forschungszentrum Berlin | Method for modulating the immune response by activating or inactivating the notch and/or stat4 signal path |
| CA2682527C (en) | 2007-03-30 | 2017-07-11 | Memorial Sloan-Kettering Cancer Center | Constitutive expression of costimulatory ligands on adoptively transferred t lymphocytes |
| EP2356270B1 (en) | 2008-11-07 | 2016-08-24 | Fabrus Llc | Combinatorial antibody libraries and uses thereof |
| WO2010059543A1 (en) | 2008-11-20 | 2010-05-27 | Merck Sharp & Dohme Corp. | Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use |
| WO2010141249A2 (en) | 2009-06-02 | 2010-12-09 | Merck Sharp & Dohme Corp. | Generation, characterization and uses thereof of anti-notch3 antibodies |
| JP6208580B2 (en) | 2010-05-17 | 2017-10-04 | サンガモ セラピューティクス， インコーポレイテッド | Novel DNA binding protein and use thereof |
| PH12013501201A1 (en) | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| WO2013126726A1 (en) | 2012-02-22 | 2013-08-29 | The Trustees Of The University Of Pennsylvania | Double transgenic t cells comprising a car and a tcr and their methods of use |
| SG10201701800YA (en) | 2012-05-25 | 2017-04-27 | Univ California | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription |
| US10316289B2 (en)* | 2012-09-06 | 2019-06-11 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of producing T memory stem cell populations |
| PL2784162T3 (en) | 2012-12-12 | 2016-01-29 | Broad Inst Inc | Engineering of systems, methods and optimized guide compositions for sequence manipulation |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| US10696946B2 (en)* | 2013-02-22 | 2020-06-30 | The Board Of Trustees Of The University Of Illinois | T-REG cell expansion |
| US9683039B2 (en) | 2013-03-14 | 2017-06-20 | New York University | Notch agonists for the treatment of cancer |
| EP3760719A1 (en) | 2013-11-18 | 2021-01-06 | CRISPR Therapeutics AG | Crispr-cas system materials and methods |
| AU2015264120A1 (en) | 2014-05-22 | 2016-11-24 | Board Of Regents Of The University Of Texas System | LILRB2 and notch-mediated expansion of hematopoietic precursor cells |
| EP3152301B1 (en) | 2014-06-04 | 2021-05-05 | Fred Hutchinson Cancer Research Center | Expansion and engraftment of stem cells using notch 1 and/or notch 2 agonists |
| MX389823B (en)* | 2014-10-27 | 2025-03-20 | Fred Hutchinson Cancer Center | COMPOSITIONS AND METHODS TO ENHANCE THE EFFICACY OF ADOPTIVE CELLULAR IMMUNOTHERAPY. |
| JP7061961B2 (en)* | 2015-10-20 | 2022-05-02 | フジフィルム セルラー ダイナミクス，インコーポレイテッド | How to induce the differentiation of pluripotent stem cells into immune cells |
| MA45488A (en)* | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | CELL CULTURE PROCESSES, KITS AND APPARATUS |
| CA3003145A1 (en)* | 2015-10-30 | 2017-05-04 | Gay M. Crooks | Methods of generating t-cells from stem cells and immunotherapeutic methods using the t-cells |
| JP7049261B2 (en)* | 2016-04-08 | 2022-04-06 | ザ ガバニング カウンシル オブ ザ ユニバーシティ オブ トロント | Methods for Producing T Progenitor Cells from Stem Cells and / or Progenitor Cells and Use of the T Progenitor Cells |
| US11261250B2 (en) | 2016-07-22 | 2022-03-01 | Fred Hutchinson Cancer Research Center | Bi-specific molecule for cell-specific Notch inhibition and related methods and compositions |